GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Cyclically Adjusted PS Ratio

Encision (Encision) Cyclically Adjusted PS Ratio : 0.56 (As of Jun. 10, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Encision Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Encision's current share price is $0.50. Encision's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.90. Encision's Cyclically Adjusted PS Ratio for today is 0.56.

The historical rank and industry rank for Encision's Cyclically Adjusted PS Ratio or its related term are showing as below:

ECIA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.13   Med: 0.42   Max: 1.41
Current: 0.56

During the past years, Encision's highest Cyclically Adjusted PS Ratio was 1.41. The lowest was 0.13. And the median was 0.42.

ECIA's Cyclically Adjusted PS Ratio is ranked better than
83.19% of 476 companies
in the Medical Devices & Instruments industry
Industry Median: 2.105 vs ECIA: 0.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Encision's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.134. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.90 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Encision Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Encision's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision Cyclically Adjusted PS Ratio Chart

Encision Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.42 0.60 0.96 0.43

Encision Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.43 0.41 0.49 0.47

Competitive Comparison of Encision's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Encision's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Encision's Cyclically Adjusted PS Ratio falls into.



Encision Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Encision's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.50/0.9
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encision's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Encision's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.134/129.4194*129.4194
=0.134

Current CPI (Dec. 2023) = 129.4194.

Encision Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.235 99.695 0.305
201406 0.232 100.560 0.299
201409 0.214 100.428 0.276
201412 0.244 99.070 0.319
201503 0.216 99.621 0.281
201506 0.230 100.684 0.296
201509 0.215 100.392 0.277
201512 0.215 99.792 0.279
201603 0.214 100.470 0.276
201606 0.213 101.688 0.271
201609 0.202 101.861 0.257
201612 0.209 101.863 0.266
201703 0.207 102.862 0.260
201706 0.221 103.349 0.277
201709 0.202 104.136 0.251
201712 0.205 104.011 0.255
201803 0.190 105.290 0.234
201806 0.225 106.317 0.274
201809 0.205 106.507 0.249
201812 0.196 105.998 0.239
201903 0.180 107.251 0.217
201906 0.167 108.070 0.200
201909 0.166 108.329 0.198
201912 0.175 108.420 0.209
202003 0.153 108.902 0.182
202006 0.116 108.767 0.138
202009 0.160 109.815 0.189
202012 0.185 109.897 0.218
202103 0.182 111.754 0.211
202106 0.173 114.631 0.195
202109 0.179 115.734 0.200
202112 0.166 117.630 0.183
202203 0.137 121.301 0.146
202206 0.179 125.017 0.185
202209 0.145 125.227 0.150
202212 0.143 125.222 0.148
202303 0.153 127.348 0.155
202306 0.140 128.729 0.141
202309 0.155 129.860 0.154
202312 0.134 129.419 0.134

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Encision  (OTCPK:ECIA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Encision Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Encision's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision (Encision) Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision (Encision) Headlines

From GuruFocus

Encision Reports First Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 08-09-2021

Encision Reports Second Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 11-10-2021

Encision Reports Second Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 11-06-2018

Encision Receives PPP Financing

By PRNewswire PRNewswire 04-23-2020

Encision Reports Fourth Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 05-14-2020

Encision Reports First Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 08-02-2018

Encision Completes Private Placement of Common Stock

By PRNewswire PRNewswire 12-20-2018

Encision Signs Supply Agreement with Auris Health, Inc.

By PRNewswire PRNewswire 08-24-2021

Encision Reports Fourth Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 05-14-2019

Encision Reports First Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 08-12-2019